Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), reached another milestone on ...

The global elastography imaging market is experiencing significant growth, with projections indicating that the industry will ...

Leading medical equipment provider recognized for its 'people-first culture,'empowering working environment supporting hospitalsHOUSTON, TX / ACCESSWIRE / November 11, 2024 / Employees at US Med-Equip ...

BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized ...

Personnel/ContractFormycon extends Management Board contract for CEO Dr. Stefan Glombitza until 2027 and receives admission to trading in the Prime Standard 11.11.2024 / 17:41 CET/CESTThe issuer is ...

ASTCT® and CIBMTR® Bring Leading Experts Together to Share Groundbreaking Advancements in Hematopoietic Cell Transplantation, Cellular Therapy and Gene Therapy. Throughout the meetings, world-class ...

Scottish Medicines Consortium Accepts Kite CAR T-Cell Therapy for Earlier Use to Treat Aggressive Blood Cancers - First SMC acceptance of any CAR T-cell therapy for lymphoma patients in the ...

New innovation drive set to inspire nurses, midwives, and AHPs to help improve NHS ScotlandFormal NHS Scotland partner InnoScot Health is launching a fresh innovation push with the aim of inspiring ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

SAN DIEGO, CA / ACCESSWIRE / November 11, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announces that it presented promising data from its ...

Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...